Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer
Clinical trial NCT00233610 · COMPLETED
Trial details
- NCT number
- NCT00233610
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-12-01
- Primary completion
- 2007-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.